PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68792-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)68792-X/fulltext
Section Title :
Section Order :
580
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68792-X&doi=10.1016/S1098-3015(10)68792-X